Goldman Sachs Group Inc Biocept Inc Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 14, 2024	BUY	$0.24 - $0.62 $2,616 - $6,759	10,903 New	10,903 $3,000
Q1 2023 May 11, 2023	BUY	$0.24 - $0.62 $2,616 - $6,759	10,903 New	10,903 $3,000
Q1 2022 May 16, 2022	SELL	$1.83 - $3.97 $38,574 - $83,683	-21,079 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.22 $6,959 - $8,562	2,029 Added 10.65%	21,079 $76,000
Q3 2021 Nov 10, 2021	BUY	$3.39 - $4.34 $64,579 - $82,677	19,050 New	19,050 $76,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.